Sunday, June 3, 2012

The FDA should have the power to go after counterfeit drugs

The FDA is responding with plans to globalize its own operations by working out mutual inspection pacts with other nations and inspecting imports based on the likelihood that a particular drug has been tampered with.

The FDA should have the power to go after counterfeit drugs - Sentinel Source.com: Guest:

"In some countries, 30 percent to 50 percent of medications are counterfeit — unlicensed knockoffs or imitations of real drugs. A new study published in the June 2012 edition of the Lancet found that about a third of the anti-malaria drugs administered in Southeast Asia and sub- Saharan Africa were either counterfeit or so poorly made that they were ineffective.

In the United States, the problem of counterfeit drugs is still relatively rare, but growing. In February, a counterfeit version of the cancer drug Avastin that contained none of the active ingredient was purchased online by various medical groups that were ignorant of the fakery."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog


SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

GMP Posters by SkillsPlus Intl Inc.

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways